SCHEMBL4879144

SCHEMBL4879144

Nc1nc(O)c2c(n1)-c1ccccc1OCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.43
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
THRB P10828 1/20 0.39
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 2/20 0.37
PIK3CA P42336 1/20 0.37
NOTUM Q6P988 1/20 0.36
HRH4 Q9H3N8 2/20 0.35
HRH2 P25021 1/20 0.35
HRH1 P35367 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
KDR P35968 2/20 0.35
ALPL P05186 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4874208 0.83 NPY5R (0.43) NPY5RKDM4EALDH1A1MEN1KMT2A
SCHEMBL4874185 0.82 MAOA (0.35) SLC9A1
SCHEMBL4879399 0.81 CTSL (0.43) KDM4ELMNATHRBADORA2AADORA1
SCHEMBL7128729 0.77 MEN1 (0.42) NPY5RKDM4EALDH1A1MEN1KMT2A
SCHEMBL4588982 0.76 HRH4 (0.57) KDM4EALDH1A1ADORA2AADORA1SMN1; SMN2
SCHEMBL602105 0.75 HRH4 (0.67) HRH4HRH2HRH1HRH3
SCHEMBL606588 0.75 HRH4 (0.69) HRH4HRH2HRH1HRH3
SCHEMBL4875687 0.74 HPGD (0.42) NPY5RKDM4EALDH1A1ADORA2AADORA1
SCHEMBL2167222 0.74 HRH4 (0.57) NPY5RKDM4EALDH1A1ADORA2AADORA1
SCHEMBL4876581 0.74 HRH4 (0.54) KDM4EALDH1A1ADORA2AADORA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735411-B2 Macrocyclic benzofused pyrimidine derivatives ABBVIE INC. (US) 2014-05-27 US disclosed
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives ABBVIE INC. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives DPYD, TYMS, UMPS NPY5R 4096/4885KDM4E 1709/4885ALDH1A1 411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.